Caribou Biosciences, Inc. (CRBU) vs Entera Bio Ltd. (ENTX)
A side-by-side comparison of Caribou Biosciences, Inc. and Entera Bio Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBU
Caribou Biosciences, Inc.
$1.17HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
ENTX
Entera Bio Ltd.
$2.57HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — CRBU vs ENTX
growth of $100 · dividends reinvested · last 5yCRBU -92.7% (-40.8%/yr)ENTX -52.1% (-13.7%/yr)ENTX compounded faster over this window
Log scale — wide-divergence pair
CRBU ENTX
CRBU vs ENTX: by the numbers
- •ENTX is the larger company ($126M vs $116M market cap).
- •Both run net losses; CRBU's is the smaller (-1030.42% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | CRBU | ENTX |
|---|---|---|
| P/S ratio | 11.56 | N/A |
| P/B ratio | 1.18 | 17.40 |
Profitability
| Metric | CRBU | ENTX |
|---|---|---|
| Gross margin | 67.34% | 0.00% |
| Operating margin | -1220.49% | -27450.00% |
| Net margin | -1030.42% | -27235.71% |
| ROE | -105.40% | -234.42% |
| ROIC | -87.72% | -82.87% |
Growth (annualized)
| Metric | CRBU | ENTX |
|---|---|---|
| Revenue CAGR (5Y) | -2.03% | N/A |
| Total return CAGR (5Y) | -44.43% | -10.57% |
Frequently asked
- How have CRBU and ENTX total returns compared?
- Over the past 5 years, CRBU delivered -44.43% and ENTX delivered -10.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.